P1114: ZANDELISIB ON INTERMITTENT DOSING AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB OR ZANUBRUTINIB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): RESULTS FROM A MU... oleh J. D. Soumerai, D. Jagadeesh, H. Salman, F. Samaniego, K. Patel, A. Stathis, N. Reddy, V. P. Kenkre, A. Asch, C. Diefenbach, I. S. Lossos, D. Persky, F. Awan, W. Huang, K. Vandever, A. D. Zelenetz